ライフサイエンスコーパス: communicable disease

1 ies (around 80% of DALYs attributable to non-communicable disease).

2 hich has a growing prevalence of chronic non-communicable disease.

3 is little evidence that they are vectors of communicable disease.

4 here three-quarters of mortality is from non-communicable disease.

5 Tuberculosis is a major communicable disease.

6 Obesity is a common cause of non-communicable disease.

7 rtality, growth failure, and adult-onset non-communicable diseases.

8 in the context of the growing burden of non-communicable diseases.

9 s with expertise in control of infection and communicable diseases.

10 h preventing and controlling the rise of non-communicable diseases.

11 d help prevent such diet-related chronic non-communicable diseases.

12 sk factors that include communicable and non-communicable diseases.

13 val and reduce disability, stunting, and non-communicable diseases.

14 tributor to adult obesity, diabetes, and non-communicable diseases.

15 and to address the emerging burden from non-communicable diseases.

16 neonatal, and nutritional causes towards non-communicable diseases.

17 k of hormone-sensitive cancers and other non-communicable diseases.

18 revalent dual burden of communicable and non-communicable diseases.

19 as obesity, diabetes, and other chronic non-communicable diseases.

20 major modifiable risk factor for chronic non-communicable diseases.

21 ealth services, but poorly in addressing non-communicable diseases.

22 eg, US$1029.10 for HIV/AIDS to $3.21 for non-communicable diseases.

23 icant heterogeneities in the transmission of communicable diseases.

24 partly because of the overwhelming burden of communicable diseases.

25 ated into management of communicable and non-communicable diseases.

26 ere diabetes must compete for resources with communicable diseases.

27 and to establish syndromic surveillance for communicable diseases.

28 ture rate of decline in communicable and non-communicable diseases.

29 with no discernible funding targeted to non-communicable diseases.

30 the effective prevention and containment of communicable diseases.

31 rt of a comprehensive strategy to reduce non-communicable diseases.

32 ammation rooted in both communicable and non-communicable diseases.

33 ould be a risk of development of chronic non communicable diseases.

34 e no detailed assessments of late-onset, non-communicable diseases.

35 ological transition from communicable to non-communicable diseases.

36 annually through its effects on multiple non-communicable diseases.

37 patterns are a global priority to reduce non-communicable diseases.

38 beginning to confront the rising tide of non-communicable diseases.

39 e richest 20% from a similar increase in non-communicable diseases (1.4 vs 5.3 years).

40 n Plan for the Prevention and Control of Non-communicable Diseases 2013-2020, and in advancing the UN

41 on precautions for patients with potentially communicable diseases; 4) proper use of personal protect

42 c health information in general (49 states), communicable diseases (42 states), and sexually transmit

43 millions of adults at increased risk of non-communicable diseases after low birthweight.

44 minants are relevant to communicable and non-communicable disease alike.

45 Transborder spread of communicable diseases also challenges communicable disea

46 tions age, and as progress continues against communicable diseases among infants and children.

47 veloping an understanding of the dynamics of communicable disease and assisting the construction and

48 The communicable disease and non-communicable disease sector

49 the UN's political commitment to address non-communicable diseases and ensure universal access to dru

50 inued to shift away from communicable to non-communicable diseases and from premature death to years

51 l persist in LICs--whereas the burden of non-communicable diseases and injuries has increased.

52 n learnt about prevention and control of non-communicable diseases and injuries, which is well summar

53 ow confronting an increasing burden from non-communicable diseases and injuries.

54 almost half of expected disability is due to communicable diseases and injuries.

55 ceed the incremental gains in decreasing non-communicable diseases and injury burdens of high-income

56 ommunicable diseases narrowed over time, non-communicable diseases and injury burdens varied markedly

57 nds in deaths caused by communicable and non-communicable diseases and injury.

58 nificant global health burdens from both non-communicable diseases and micronutrient deficiencies.

59 rly 90% of expected disability is due to non-communicable diseases and most of the remainder to injur

60 ns, while at the same time, diet-related non-communicable diseases and obesity have exponentially inc

61 Urgent action is now required to control non-communicable diseases and reduce fatal injuries in Mexic

62 onal differences in the unfinished agenda of communicable diseases and reproductive, maternal, and ch

63 e solution is city planning that reduces non-communicable diseases and road trauma while also managin

64 of infections allows treatment of potential communicable diseases and updating of immunizations.

65 is study shows the reversal of HIV/AIDS, non-communicable disease, and injury mortality trends in Sou

66 side from HIV/AIDS, few CL episodes involved communicable disease, and none occurred in least-develop

67 tal, and nutritional disorders, 43% from non-communicable diseases, and 10% from injuries.

68 alth security, antimicrobial resistance, non-communicable diseases, and climate change-but also the t

69 rders increase risk for communicable and non-communicable diseases, and contribute to unintentional a

70 (MDGs), addressing growing challenges of non-communicable diseases, and ensuring universal health cov

71 Mortality from tuberculosis, non-communicable diseases, and injuries decreased slightly.

72 rnal, perinatal, and nutritional causes, non-communicable diseases, and injury.

73 al budget to infectious diseases, 12% to non-communicable diseases, and less than 1% to injuries and

74 ogenic agents is likely to prevent other non-communicable diseases, and the cause could be removed or

75 ns when caring for patients with potentially communicable diseases; and 5) evaluation of personnel wi

76 atal, and nutritional disorders; second, non-communicable diseases; and third, injuries.

77 dult mortality risks from infections and non-communicable diseases are a result of historical childho

78 Non-communicable diseases are increasingly common causes of

79 poor, which population interventions for non-communicable diseases are most applicable in different c

80 Non-communicable diseases are the leading global cause of de

81 Non-communicable diseases are, however, already major public

82 Since this transition, the prevention of non-communicable disease as well as communicable disease cau

83 ciation between socioeconomic status and non-communicable disease behavioural risk factors is well es

84 an ageing global population comes major non-communicable disease burden, especially in low-income an

85 itiative, a plan to cut mortality due to non-communicable diseases by 25% by 2025.

86 tobacco use and premature mortality from non-communicable diseases by a third by 2030.

87 re developed for key nutrients linked to non communicable diseases by an independent scientific commi

88 ct of physical inactivity on these major non-communicable diseases by estimating how much disease cou

89 l to reduce rates of death from chronic (non-communicable) disease by an additional 2% every year.

90 vative assumptions for each of the major non-communicable diseases, by country, to estimate how much

91 ch about half the mortality reduction in non-communicable diseases called for by the Sustainable Deve

92 ing factual information about the dangers of communicable diseases can positively impact people's att

93 Among chronic non-communicable diseases, cardiometabolic diseases and canc

94 den of Disease Study 2010, the burden of non-communicable diseases (cardiovascular disease, cancer, c

95 Diphtheria is an acute, communicable disease caused by Corynebacterium diphtheri

96 In 1990, communicable diseases caused 59% of death and disability

97 world's richest 20%, on the other hand, non-communicable diseases caused 85% of death and disability

98 ntion of non-communicable disease as well as communicable disease causes of adolescent mortality has

99 became the first chief epidemiologist at the Communicable Disease Center (CDC) in Atlanta, Georgia.

100 He was hired by the US Communicable Disease Center (now the Centers for Disease

101 When the Communicable Disease Center (now the Centers for Disease

102 I outline the Communicable Disease Center's first surveillance systems

103 The Communicable Disease Center, now the Centers for Disease

104 alth Service, which at the time included the Communicable Disease Center, the Centers for Disease Con

105 rganization was notified of an outbreak of a communicable disease characterized by fever, severe diar

106 However, amid Mexico's progress against communicable diseases, chronic kidney disease burden rap

107 ead of communicable diseases also challenges communicable disease control systems within the EU.

108 stems are to meet the emerging challenges to communicable disease control.

109 entation of an effective response to the non-communicable-disease crisis will need political commitme

110 A raised baseline rate of communicable disease decline between 1990 and 2020 would

111 National Institute for Communicable Diseases: Division of the National Health L

112 individuals towards risk of Diet Related Non-communicable Diseases (DR-NCDs).

113 al Administrative Region, Harvard Center for Communicable Disease Dynamics from the National Institut

114 ramme and Wellcome Trust, Harvard Center for Communicable Disease Dynamics, and Health and Medical Re

115 The changing patterns of communicable diseases east of the EU's new border has im

116 child health, other infectious diseases, non-communicable diseases, Ebola, and sector-wide approaches

117 Development Goals and the challenges of non-communicable diseases, economic inequality, and climate

118 DALYs from non-communicable diseases--especially ischaemic heart diseas

119 isorders including diabetes, cardiovascular, communicable diseases etc.

120 uintile for HIV/AIDS and tuberculosis, other communicable diseases (excluding HIV/AIDS and tuberculos

121 rominently in the burgeoning epidemic of non-communicable diseases facing low- and middle-income coun

122 rders accounted for 17.2 million deaths, non-communicable diseases for 28.1 million deaths and injuri

123 illness (ILI) to the National Institute for Communicable Diseases for influenza testing by immunoflu

124 5) evaluation of personnel with exposure to communicable diseases for receipt of postexposure prophy

125 e burden of morbidity and mortality from non-communicable disease has risen worldwide and is accelera

126 logical evidence, the policy response to non-communicable diseases has been weak.

127 High rates of non-communicable diseases have also been described with evid

128 wever, socioeconomic factors influencing non-communicable diseases have not been included in the plan

129 iven to the issue of access to medicines for communicable diseases; however, access to essential medi

130 ctors that have contributed to the growth of communicable disease in Russia, Ukraine, and Belarus; se

131 edictive values (PPVs) of ICD-9-CM codes for communicable diseases in 6 North Carolina health-care sy

132 e diseases in children towards those for non-communicable diseases in adults.

133 society by preventing and treating not only communicable diseases in all ages, but also noncommunica

134 Asthma-one of the most common chronic, non-communicable diseases in children and adults-is characte

135 stantially, with a shift away from risks for communicable diseases in children towards those for non-

136 han 3 million deaths per year, most from non-communicable diseases in low-income and middle-income co

137 Global and regional estimates show that non-communicable diseases in old age are rising in importanc

138 , care, and treatment, and management of non-communicable diseases in the poorest populations.

139 2008, with 446 annual excess deaths from non-communicable diseases in the UK (280 for young people ag

140 Mortality from non-communicable diseases in the UK fell from being roughly

141 has been among the most frequently reported communicable diseases in the United States since 1960.

142 ight the need to focus more attention on non-communicable diseases in this population and balance obe

143 nges of contact tracing for high-consequence communicable diseases included rapid comprehensive conta

144 s early life factors in the aetiology of non-communicable diseases, including asthma/wheezing disorde

145 Non-communicable diseases, including cancer, are overtaking

146 The most common non-communicable diseases, including ischaemic heart disease

147 rly for infant deaths and mortality from non-communicable diseases, including neuropsychiatric disord

148 reflected in changes in the epidemiology of communicable diseases, including tuberculosis and HIV (i

149 everal risks that primarily affect childhood communicable diseases, including unimproved water and sa

150 hy eating guidelines that aim to prevent non-communicable diseases (increase fruits, vegetables, whol

151 Deaths from non-communicable diseases increased over time in both sexes,

152 As the prevalence of injuries and non-communicable diseases increases, the provision of effect

153 and diagnostic yield of integrating NCD and communicable diseases into a rapid HIV testing and refer

154 ty of integrating hypertension, diabetes and communicable diseases into HIV initiatives.

155 obability of a man or woman dying from a non-communicable disease is higher in sub-Saharan Africa and

156 ntries in the Gulf region, the burden of non-communicable diseases is a major threat, primarily due t

157 and increasing burden of mortality from non-communicable diseases is likely to become prominent.

158 by mass drug administration programs against communicable diseases may necessitate increased vector c

159 ated at the international level, such as non-communicable diseases, mental health, and injuries.

160 opment Goal (SDG) 3.4-reducing premature non-communicable disease mortality by a third by 2030-should

161 We projected that non-communicable disease mortality will increase from 28.1 m

162 e varied substantially by health topic, from communicable diseases (n=131), nutrition (n=77), to non-

163 e diseases (n=131), nutrition (n=77), to non-communicable diseases (n=8), and water, sanitation, and

164 Although state inequalities from communicable diseases narrowed over time, non-communicab

165 disease contributes substantially to the non-communicable disease (NCD) burden in low-income and midd

166 age and gender, by communicable (CD) and non-communicable disease (NCD) causes.

167 ession was used to analyse all-cause and non-communicable disease (NCD) mortality between 2006 and 20

168 Heightened risk of non-communicable diseases (NCD) in children exposed to SAM a

169 income countries, care for patients with non-communicable diseases (NCDs) and mental health condition

170 e premature mortality from the four main non-communicable diseases (NCDs) by 25% from 2010 levels by

171 approaches to prevention and control of non-communicable diseases (NCDs) have been elaborated in the

172 The burden of non-communicable diseases (NCDs) is disproportionately carri

173 Non-communicable diseases (NCDs) such as cardiovascular dise

174 unities have a higher risk of dying from non-communicable diseases (NCDs) than do more advantaged gro

175 xperiencing an increase in the burden of non-communicable diseases (NCDs), including cancer.

176 of 30 years and 70 years) from four main non-communicable diseases (NCDs)--cardiovascular diseases, c

177 vide an untapped opportunity to identify non-communicable diseases (NCDs).

178 le will increasingly develop age-related non-communicable diseases (NCDs).

179 deaths; a third of premature deaths from non-communicable diseases (NCDs); and a third of those from

180 The threat of non-communicable diseases ("NCDs") is increasingly becoming

181 action: malaria 8.0% and syphilis 7.7%), non-communicable diseases, nutrition and lifestyle factors (

182 Sequencing pathogen samples during a communicable disease outbreak is becoming an increasingl

183 he HIV epidemic, and increasing rates of non-communicable diseases, people in sub-Saharan Africa are

184 Cancer is one of the major non-communicable diseases posing a threat to world health.

185 Despite mortality due to communicable diseases, poverty, and human conflicts, dem

186 Growing political recognition of non-communicable diseases provides a favourable political co

187 The rise in diabetes and other non-communicable diseases puts a heavy toll on health system

188 rs, due to population ageing, changes in non-communicable disease rates, and increasing air pollution

189 s and regions, although communicable and non-communicable diseases remained the main causes of death

190 Controlling an emerging communicable disease requires prompt adoption of measure

191 of diets associated with lower or higher non-communicable disease risk on the basis of multivariate m

192 Deaths from non-communicable diseases rose by just under 8 million betwe

193 focus areas (other infectious diseases, non-communicable diseases, sector-wide approaches, and other

194 The communicable disease and non-communicable disease sectors need to move beyond convent

195 In the 1960s and 1970s, communicable disease seemed a minor threat, but since th

196 cal guidelines for GAS pharyngitis and other communicable diseases should be considered for reducing

197 t in the global monitoring framework for non-communicable diseases should promote accountability for

198 Treatment of non-communicable diseases such as cancer in refugees is negl

199 verse health conditions, including major non-communicable diseases such as coronary heart disease, ty

200 f many pathologies, particularly chronic non-communicable diseases such as obesity and diabetes.

201 s, one can find regions having predominantly communicable diseases such as rheumatic heart disease, t

202 ses has provoked a renewed focus on European communicable disease surveillance and control.

203 dated hospital discharge data unsuitable for communicable disease surveillance.

204 Worldwide, communicable and non-communicable diseases tend to segregate geographically.

205 We assess risks of communicable diseases that are associated with mass gath

206 coronary heart disease and other chronic non-communicable diseases that lower global life expectancie

207 nfancy and childhood as well as chronic, non-communicable diseases that may manifest at any point acr

208 Unlike most communicable diseases, the absolute burden and relative

209 transitions from diseases of poverty to non-communicable diseases, the burden of disease and health

210 n accelerated rate of overall decline in non-communicable diseases, the poor-rich gap would widen.

211 stablished U.S. guidelines for visitors with communicable diseases, thereby not limiting the rights o

212 e to worldwide epidemics of injuries and non-communicable diseases through traffic exposure, noise, a

213 DC from an agency focused almost entirely on communicable diseases to one engaged in a broad array of

214 The burden of non-communicable diseases, to which cancer contributes great

215 Among communicable diseases, tuberculosis is the second leadin

216 nd a third of those from other causes (other communicable diseases, undernutrition, and injuries).

217 f patient charts with ICD-9-CM diagnoses for communicable diseases were reviewed and evaluated for th

218 Substantial declines in death caused by communicable diseases were seen in all age-groups and re

219 n treatment, blood glucose level, having non-communicable diseases were significantly associated with

220 Most increases in DALYs, especially from non-communicable diseases, were due to population growth.

221 ies (around 50% of DALYs attributable to non-communicable disease), whereas China more closely resemb

222 ed by a novel coronavirus (CoV), is a highly communicable disease with the lungs as the major patholo

223 culosis remains one of the world's deadliest communicable diseases with 10 million incident cases and

224 herapies include commonly used drugs for non-communicable diseases with good safety profiles, immunom

225 ity on addressing the high prevalence of non-communicable diseases, with variations in policies betwe

226 al artery disease is a prevalent chronic non-communicable disease without obvious symptoms.

227 As a result, a faster decline in communicable diseases would decease the poor-rich gap in